WEBSITE BSE:526821 NSE : DAI-ICHI KAR 18 May, 12:50
Market Cap ₹441 Cr.
Stock P/E 32.9
P/B 2.5
Current Price ₹591.5
Book Value ₹ 240.5
Face Value 10
52W High ₹666
Dividend Yield 0.68%
52W Low ₹ 326.7
Dai-Ichi Karkaria Ltd is a globally recognized chemical manufacturing company headquartered in Mumbai, India. With a rich history spanning several decades, the company has established itself as a leading provider of specialty chemicals, polymers, and coatings for various industries. Dai-Ichi Karkaria has a diverse product portfolio, catering to sectors such as pharmaceuticals, personal care, textiles, paints and coatings, agrochemicals, and more. The company's commitment to research and development enables them to consistently innovate and deliver high-quality products that meet stringent industry standards. Their state-of-the-art manufacturing facilities are equipped with advanced technologies, ensuring efficiency and sustainability in production processes. Dai-Ichi Karkaria's success is attributed to their focus on customer satisfaction, offering customized solutions, technical expertise, and reliable after-sales support. They have a strong global presence, serving customers in over 50 countries through an extensive network of subsidiaries, agents, and distributors. Driven by their core values of integrity, quality, and sustainability, Dai-Ichi Karkaria continues to be a trusted partner for industries worldwide, providing innovative chemical solutions for diverse applications.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 26 | 30 | 31 | 38 | 54 | 49 | 42 | 28 | 35 | 35 |
Other Income | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
Total Income | 27 | 32 | 32 | 40 | 56 | 51 | 44 | 29 | 36 | 36 |
Total Expenditure | 31 | 34 | 36 | 39 | 49 | 42 | 37 | 28 | 33 | 33 |
Operating Profit | -4 | -3 | -4 | 0 | 7 | 9 | 6 | 0 | 3 | 3 |
Interest | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 4 | 0 | 7 | 3 | 0 | 0 | 21 | 0 |
Profit Before Tax | -6 | -5 | -2 | -2 | 12 | 9 | 3 | -3 | 20 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 4 | -0 | 5 | -0 |
Profit After Tax | -6 | -5 | -2 | -2 | 12 | 9 | -0 | -3 | 15 | 1 |
Adjustments | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -0 | 1 |
Profit After Adjustments | -7 | -5 | -1 | -2 | 12 | 9 | 1 | -3 | 15 | 1 |
Adjusted Earnings Per Share | -8.7 | -6.6 | -1.9 | -2.6 | 16.5 | 12.3 | 0.8 | -3.9 | 19.6 | 1.5 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 102 | 147 | 181 | 194 | 126 | 147 | 92 | 107 | 97 | 122 | 184 | 140 |
Other Income | 5 | 4 | 8 | 4 | 12 | 6 | 3 | 4 | 5 | 4 | 6 | 4 |
Total Income | 107 | 151 | 189 | 198 | 138 | 153 | 96 | 111 | 102 | 126 | 190 | 145 |
Total Expenditure | 96 | 134 | 159 | 162 | 109 | 132 | 103 | 112 | 111 | 140 | 168 | 131 |
Operating Profit | 11 | 17 | 30 | 37 | 30 | 21 | -8 | -1 | -9 | -14 | 22 | 12 |
Interest | 0 | 1 | 0 | 1 | 0 | 0 | 7 | 10 | 9 | 1 | 3 | 3 |
Depreciation | 2 | 2 | 5 | 2 | 2 | 4 | 8 | 9 | 9 | 7 | 7 | 8 |
Exceptional Income / Expenses | 0 | 6 | 7 | 0 | 0 | 0 | -1 | -4 | 82 | 4 | 10 | 21 |
Profit Before Tax | 9 | 20 | 32 | 34 | 27 | 16 | -24 | -25 | 56 | -18 | 22 | 20 |
Provision for Tax | 2 | 5 | 9 | 12 | 7 | 4 | -12 | 0 | 7 | 0 | 4 | 9 |
Profit After Tax | 7 | 16 | 23 | 22 | 21 | 12 | -13 | -25 | 48 | -18 | 18 | 13 |
Adjustments | -0 | -0 | -0 | -0 | 4 | 2 | 0 | 2 | 2 | 0 | 2 | 2 |
Profit After Adjustments | 7 | 16 | 23 | 22 | 25 | 14 | -13 | -23 | 51 | -18 | 20 | 14 |
Adjusted Earnings Per Share | 8.8 | 20.9 | 31.2 | 29.3 | 33.4 | 18.3 | -16.9 | -30.8 | 68 | -24.2 | 26.9 | 18 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 51% | 20% | 5% | 6% |
Operating Profit CAGR | 0% | 0% | 1% | 7% |
PAT CAGR | 0% | 0% | 8% | 10% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 51% | 16% | 22% | 23% |
ROE Average | 12% | 11% | 1% | 9% |
ROCE Average | 13% | 12% | 4% | 14% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 74 | 87 | 108 | 126 | 150 | 159 | 143 | 120 | 170 | 150 | 170 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 1 | 1 | 1 | 1 | 4 | 60 | 73 | 68 | 0 | 4 | 17 |
Other Non-Current Liabilities | 2 | 1 | 21 | 26 | 2 | 38 | 26 | 27 | 35 | 35 | 22 |
Total Current Liabilities | 20 | 29 | 36 | 30 | 23 | 54 | 64 | 80 | 66 | 58 | 58 |
Total Liabilities | 97 | 119 | 167 | 184 | 179 | 311 | 306 | 295 | 272 | 247 | 267 |
Fixed Assets | 17 | 17 | 16 | 17 | 20 | 94 | 164 | 153 | 105 | 105 | 139 |
Other Non-Current Assets | 17 | 19 | 42 | 61 | 68 | 118 | 70 | 68 | 75 | 73 | 59 |
Total Current Assets | 64 | 83 | 108 | 106 | 91 | 100 | 72 | 74 | 93 | 67 | 68 |
Total Assets | 97 | 119 | 167 | 184 | 179 | 311 | 306 | 295 | 272 | 247 | 267 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 3 | 7 | 5 | 7 | 4 | 2 | 4 | 5 | 1 | 12 | 2 |
Cash Flow from Operating Activities | -4 | 4 | 5 | 11 | 3 | -8 | 6 | 1 | -22 | -3 | 23 |
Cash Flow from Investing Activities | 9 | -3 | -0 | -8 | -7 | -57 | -21 | 1 | 130 | -4 | -33 |
Cash Flow from Financing Activities | -2 | -3 | -3 | -6 | 2 | 66 | 16 | -6 | -97 | -2 | 13 |
Net Cash Inflow / Outflow | 4 | -2 | 3 | -3 | -2 | 2 | 2 | -4 | 11 | -10 | 4 |
Closing Cash & Cash Equivalent | 7 | 5 | 7 | 4 | 2 | 4 | 5 | 1 | 12 | 2 | 6 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 8.83 | 20.94 | 31.25 | 29.34 | 33.44 | 18.32 | -16.93 | -30.77 | 68.03 | -24.2 | 26.94 |
CEPS(Rs) | 10.95 | 23.21 | 37.38 | 32.45 | 30.75 | 22.08 | -6.04 | -20.78 | 76.44 | -15.4 | 34.79 |
DPS(Rs) | 2.5 | 2.5 | 2.5 | 3 | 3 | 2.5 | 0 | 0 | 3 | 0 | 4 |
Book NAV/Share(Rs) | 94.53 | 112.45 | 140.59 | 164.93 | 201.17 | 213.19 | 191.54 | 160.6 | 228.82 | 201.21 | 228.05 |
Core EBITDA Margin(%) | 5.37 | 8.19 | 11.75 | 15.96 | 13.03 | 10.25 | -11.62 | -4.7 | -13.84 | -14.92 | 8.68 |
EBIT Margin(%) | 8.49 | 13.25 | 17.24 | 16.95 | 20.59 | 11.12 | -18.42 | -13.64 | 66.42 | -13.63 | 13.75 |
Pre Tax Margin(%) | 8.2 | 12.91 | 17.01 | 16.56 | 20.52 | 10.99 | -26.21 | -23.14 | 57.03 | -14.84 | 12.09 |
PAT Margin (%) | 5.98 | 9.87 | 12.23 | 10.8 | 15.59 | 8.04 | -13.59 | -23.14 | 49.48 | -14.84 | 10.1 |
Cash Profit Margin (%) | 7.42 | 10.94 | 14.63 | 11.94 | 17.1 | 11.04 | -4.84 | -14.37 | 58.17 | -9.32 | 14.18 |
ROA(%) | 7.06 | 14.43 | 16.31 | 12.46 | 11.5 | 4.88 | -4.09 | -8.3 | 17.09 | -7.04 | 7.19 |
ROE(%) | 9.64 | 20.24 | 24.7 | 19.21 | 15.32 | 7.76 | -8.38 | -19.01 | 33.39 | -11.41 | 11.55 |
ROCE(%) | 13.43 | 26.73 | 34.41 | 29.83 | 19.85 | 8.51 | -7.1 | -6.2 | 31.07 | -9.26 | 13.25 |
Receivable days | 57.33 | 57.97 | 64.88 | 67.19 | 78.28 | 62.21 | 91.91 | 62.54 | 82.38 | 61.38 | 44.27 |
Inventory Days | 36.38 | 29.55 | 29.06 | 29.24 | 43.9 | 43.59 | 71.41 | 63.41 | 83.63 | 70.1 | 41.9 |
Payable days | 65.22 | 58.47 | 77.41 | 88.1 | 95.23 | 68.94 | 125.95 | 129.66 | 182.69 | 140.31 | 89.16 |
PER(x) | 4.42 | 2.57 | 5.02 | 11.9 | 14.84 | 21.61 | 0 | 0 | 4.38 | 0 | 13.44 |
Price/Book(x) | 0.41 | 0.48 | 1.12 | 2.12 | 2.47 | 1.86 | 1.07 | 1.09 | 1.3 | 1.82 | 1.59 |
Dividend Yield(%) | 6.41 | 4.65 | 1.59 | 0.86 | 0.6 | 0.63 | 0 | 0 | 1.01 | 0 | 1.1 |
EV/Net Sales(x) | 0.19 | 0.23 | 0.59 | 1.3 | 2.93 | 2.48 | 2.7 | 2.19 | 2.33 | 2.37 | 1.63 |
EV/Core EBITDA(x) | 1.79 | 2.03 | 3.56 | 6.88 | 12.45 | 17.33 | -33.06 | -189.49 | -26.34 | -20.62 | 13.42 |
Net Sales Growth(%) | 31.69 | 45.03 | 22.81 | 7.09 | -35 | 16.6 | -37.13 | 16.05 | -9.1 | 25.07 | 50.97 |
EBIT Growth(%) | 64.6 | 124.3 | 56.69 | 4.49 | -19.58 | -39.94 | -203.32 | 14.14 | 542.38 | -125.8 | 249.88 |
PAT Growth(%) | 55.31 | 137.25 | 49.22 | -6.1 | -4.45 | -42.65 | -205.43 | -97.47 | 294.23 | -137.72 | 201.09 |
EPS Growth(%) | 55.31 | 137.25 | 49.22 | -6.1 | 13.96 | -45.2 | -192.38 | -81.76 | 321.12 | -135.58 | 211.31 |
Debt/Equity(x) | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.48 | 0.73 | 0.91 | 0.12 | 0.14 | 0.22 |
Current Ratio(x) | 3.18 | 2.86 | 3.01 | 3.47 | 3.91 | 1.84 | 1.13 | 0.92 | 1.4 | 1.17 | 1.19 |
Quick Ratio(x) | 2.59 | 2.38 | 2.55 | 2.95 | 3.21 | 1.49 | 0.86 | 0.67 | 1.04 | 0.77 | 0.85 |
Interest Cover(x) | 29.32 | 38.87 | 74.33 | 43.62 | 275.9 | 82.85 | -2.36 | -1.44 | 7.07 | -11.26 | 8.27 |
Total Debt/Mcap(x) | 0.05 | 0.03 | 0.01 | 0.01 | 0.01 | 0.26 | 0.68 | 0.83 | 0.09 | 0.08 | 0.14 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.35 | 0.35 | 0.35 | 0 | 0 |
Public | 35.69 | 35.69 | 35.69 | 35.69 | 35.69 | 35.77 | 35.77 | 35.77 | 36.12 | 36.12 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About